The study, which used data from Sleep Number®
smart beds, was presented at the Heart Failure Society of America
Annual Scientific Meeting
Today, Sleep Number Corporation (Nasdaq: SNBR), a wellness
technology leader, announced new research presented at the Heart
Failure Society of America (HFSA) Annual Scientific Meeting in
Cleveland. Data presented show results of a study in collaboration
with investigators at Mayo Clinic analyzing the connection between
sleep abnormalities and heart failure with preserved ejection
fraction (HFpEF), the most common cause of heart failure. The
study, titled "Sleep Abnormalities Among Community Participants at
Risk for Heart Failure," leveraged longitudinal sleep data from
Sleep Number smart beds with Mayo Clinic’s AI capabilities and
clinical expertise.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20231016764432/en/
Today, Sleep Number Corporation announced
new research presented at the Heart Failure Society of America
Annual Scientific Meeting in Cleveland. Data presented show results
of a study in collaboration with investigators at Mayo Clinic
analyzing the connection between sleep abnormalities and heart
failure with preserved ejection fraction (HFpEF), the most common
cause of heart failure. (Graphic: Business Wire)
In recent years, the prevalence of heart failure has increased,
which is linked to a rise in HFpEF. This is a common but
life-threatening syndrome in which the heart does not adequately
relax between each heartbeat, so the pressure inside the heart
rises. Diagnosing HFpEF can be challenging, since a physician can’t
detect it based on symptoms alone. Existing diagnostic criteria are
obtrusive, requiring the use of tests such as cardiac
catheterization or an echocardiogram, often during exercise. As a
result, the prevalence of HFpEF is severely underreported.
It is also true that sleep disorders such as insomnia and sleep
apnea are associated with metabolic health and heart failure. To
estimate the probability of HFpEF and understand the link between
HFpEF and sleep quality, Mayo Clinic researchers developed an HFpEF
probability model based on age and BMI. They then validated this
model using exercise right heart catheterization, which helps
physicians understand how well the heart is working when one is
active or exercising. Researchers then collaborated with Sleep
Number Corporation to analyze a month’s worth of de-identified
sleep data from 91,954 Sleep Number® smart bed sleepers and
self-reported sleep survey data submitted by 5,861 of those smart
bed sleepers. Results will show the relation between HFpEF and
sleep in a real-world, home environment.
The study was led by Dr. Yogesh N.V. Reddy, a board-certified
invasive cardiologist and heart failure specialist, and Consultant
in the Circulatory Failure Division and Cardiac Catheterization
laboratory at Mayo Clinic. Dr. Reddy is a preeminent researcher
focused on diagnosis and treatment of HFpEF, pulmonary hypertension
and exercise physiology.
“By connecting sleep disturbances and HFpEF risk, this study
could suggest that addressing sleep issues may potentially play a
role in preventing or managing heart failure,” said Raj Mills, Vice
President, SleepIQ Health and Research, Sleep Number. “Our joint
research introduces a new, potentially valuable tool for early
detection of HFpEF, allowing for timely monitoring, lifestyle
adjustments and medical intervention. This could improve health
care quality and outcomes. The broader public health implications
of this research are vast, as they could lead to better-targeted
preventive measures, more accurate diagnoses and improved
management strategies for those at risk of HFpEF.”
Sleep Number has over 22 billion hours’ worth of highly accurate
sleep and biosignal data from its millions of Smart Sleepers.
Today, the data are used by global research institutions to
understand the impact of sleep on health, and advance sleep science
with individualized, actionable insights not previously available
without an in-lab sleep study.
In the future, these proprietary data can potentially be
instrumental in securing funded studies enabling research on a
global scale, in partnership with physicians, health systems and
research institutions. The data will also be used to bring new
health and wellness solutions to our smart sleeper community.
“This novel study highlights not only the important relationship
between sleep and cardiovascular health, but also the ways in which
wellness technology companies can meaningfully connect real-world,
longitudinal data with research to advance understanding of health
outcomes,” said Annie Bloomquist, Executive Vice President and
Chief Innovation Officer, Sleep Number. “Sleep Number was integral
to the success of this study; our data and smart sleepers enabled
Mayo Clinic researchers to validate their AI model and findings. In
the future, we intend to deliver connected sleep health and
wellness solutions, and our collaboration with Mayo Clinic on this
important study is validation that we are one step closer to
delivering on that goal.”
To learn more, visit sleepnumber.com/science or our
newsroom.
About Sleep Number Corporation
Sleep Number is a wellness technology company. We are guided by
our purpose to improve the health and wellbeing of society through
higher quality sleep; to date, our innovations have improved over
14.5 million lives. Our wellness technology platform helps solve
sleep problems, whether it’s providing individualized temperature
control for each sleeper through our Climate360® smart bed or
applying our 22 billion hours of longitudinal sleep data and
expertise to research with global institutions.
Our smart bed ecosystem drives best-in-class engagement through
dynamic, adjustable, and effortless sleep with personalized digital
sleep and health insights; our millions of smart sleepers are loyal
brand advocates. And our nearly 5,000 mission-driven team members
passionately innovate to drive value creation through our
vertically integrated business model, including our exclusive
direct-to-consumer selling in 675 stores and online.
To learn more about life-changing, individualized sleep, visit a
Sleep Number store near you, our newsroom and investor relations
sites, or SleepNumber.com.
Forward-looking Statements
Statements used in this news release relating to future plans,
such as statements about our joint research to advance sleep
science, intention to deliver connected sleep health and wellness
solutions, and our continued research collaboration with global
institutions, are forward-looking statements subject to certain
risks and uncertainties. Additional information concerning these,
and other risks and uncertainties, is contained in the company’s
filings with the Securities and Exchange Commission (SEC),
including the Annual Report on Form 10-K, and other periodic
reports filed with the SEC. The company has no obligation to
publicly update or revise any of the forward-looking statements in
this news release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231016764432/en/
Nichole Teixeira Sleep Number Public Relations
Nichole.Teixeira@sleepnumber.com
Sleep Number (NASDAQ:SNBR)
Historical Stock Chart
From Apr 2024 to May 2024
Sleep Number (NASDAQ:SNBR)
Historical Stock Chart
From May 2023 to May 2024